On November 2, 2023, Vivos Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.125 USD | -2.97% | -19.20% | -82.92% |
Apr. 01 | Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures | MT |
Apr. 01 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.92% | 6.34M | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
+42.58% | 5.1B | |
-19.05% | 4.05B | |
-32.61% | 2.54B | |
-0.74% | 1.99B | |
+10.80% | 1.99B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Vivos Therapeutics, Inc. announced that it has received $4.000003 million in funding